118 related articles for article (PubMed ID: 15020221)
21. The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response.
Sawa T
J Intensive Care; 2014; 2(1):10. PubMed ID: 25520826
[TBL] [Abstract][Full Text] [Related]
22. Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.
Benson MA; Komas SM; Schmalzer KM; Casey MS; Frank DW; Feix JB
Biophys J; 2011 Mar; 100(5):1335-43. PubMed ID: 21354407
[TBL] [Abstract][Full Text] [Related]
23. Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU.
Saliba AM; de Assis MC; Nishi R; Raymond B; Marques Ede A; Lopes UG; Touqui L; Plotkowski MC
Microbes Infect; 2006 Feb; 8(2):450-9. PubMed ID: 16293434
[TBL] [Abstract][Full Text] [Related]
24. A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.
Rabin SD; Veesenmeyer JL; Bieging KT; Hauser AR
Infect Immun; 2006 May; 74(5):2552-61. PubMed ID: 16622190
[TBL] [Abstract][Full Text] [Related]
25. ExoU modulates soluble and membrane-bound ICAM-1 in Pseudomonas aeruginosa-infected endothelial cells.
Lins RX; de Assis MC; Mallet de Lima CD; Freitas C; Maciel Plotkowski MC; Saliba AM
Microbes Infect; 2010 Feb; 12(2):154-61. PubMed ID: 19931407
[TBL] [Abstract][Full Text] [Related]
26. ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells.
Plotkowski MC; Feliciano LF; Machado GB; Cunha LG; Freitas C; Saliba AM; de Assis MC
Eur Respir J; 2008 Dec; 32(6):1591-8. PubMed ID: 18684846
[TBL] [Abstract][Full Text] [Related]
27. Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia.
Howell HA; Logan LK; Hauser AR
mBio; 2013 Mar; 4(2):e00032-13. PubMed ID: 23481600
[TBL] [Abstract][Full Text] [Related]
28. Central role of PAFR signalling in ExoU-induced NF-κB activation.
Mallet de Lima CD; da Conceição Costa J; de Oliveira Lima Santos SA; Carvalho S; de Carvalho L; Albano RM; Teixeira MM; Plotkowski MC; Saliba AM
Cell Microbiol; 2014 Aug; 16(8):1244-54. PubMed ID: 24612488
[TBL] [Abstract][Full Text] [Related]
29. Traversal of multilayered corneal epithelia by cytotoxic Pseudomonas aeruginosa requires the phospholipase domain of exoU.
Ramirez JC; Fleiszig SM; Sullivan AB; Tam C; Borazjani R; Evans DJ
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):448-53. PubMed ID: 22167094
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of a phospholipase A1 activity type three secreted protein, PP_ExoU from Pseudomonas plecoglossicida NB2011, the causative agent of visceral granulomas disease in large yellow croaker (Larimichthys crocea).
Zhang J; Wang Y; Guo H; Mao Z; Ge C
J Fish Dis; 2017 Jun; 40(6):831-840. PubMed ID: 27734506
[TBL] [Abstract][Full Text] [Related]
31. A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA(2) activity.
Benson MA; Schmalzer KM; Frank DW
Clin Chim Acta; 2010 Feb; 411(3-4):190-7. PubMed ID: 19900431
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia.
Diaz MH; Hauser AR
Infect Immun; 2010 Apr; 78(4):1447-56. PubMed ID: 20100855
[TBL] [Abstract][Full Text] [Related]
33. The manifold phospholipases A of Legionella pneumophila - identification, export, regulation, and their link to bacterial virulence.
Banerji S; Aurass P; Flieger A
Int J Med Microbiol; 2008 Apr; 298(3-4):169-81. PubMed ID: 18178130
[TBL] [Abstract][Full Text] [Related]
34. Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.
Anderson DM; Feix JB; Monroe AL; Peterson FC; Volkman BF; Haas AL; Frank DW
J Biol Chem; 2013 Sep; 288(37):26741-52. PubMed ID: 23908356
[TBL] [Abstract][Full Text] [Related]
35. Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A
Tessmer MH; Anderson DM; Buchaklian A; Frank DW; Feix JB
J Biol Chem; 2017 Feb; 292(8):3411-3419. PubMed ID: 28069812
[TBL] [Abstract][Full Text] [Related]
36. Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU.
Tyson GH; Hauser AR
Infect Immun; 2013 Aug; 81(8):2873-81. PubMed ID: 23716613
[TBL] [Abstract][Full Text] [Related]
37. Genotypic and phenotypic analysis of type III secretion system in a cohort of Pseudomonas aeruginosa bacteremia isolates: evidence for a possible association between O serotypes and exo genes.
Berthelot P; Attree I; Plésiat P; Chabert J; de Bentzmann S; Pozzetto B; Grattard F;
J Infect Dis; 2003 Aug; 188(4):512-8. PubMed ID: 12898437
[TBL] [Abstract][Full Text] [Related]
38. Intoxication of host cells by the T3SS phospholipase ExoU: PI(4,5)P2-associated, cytoskeletal collapse and late phase membrane blebbing.
Sato H; Frank DW
PLoS One; 2014; 9(7):e103127. PubMed ID: 25061861
[TBL] [Abstract][Full Text] [Related]
39. Regiospecificity and catalytic triad of lysophospholipase I.
Wang A; Loo R; Chen Z; Dennis EA
J Biol Chem; 1997 Aug; 272(35):22030-6. PubMed ID: 9268342
[TBL] [Abstract][Full Text] [Related]
40. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
Shaver CM; Hauser AR
Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
